GeoVax Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 16 - Ongoing Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ongoing Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ongoing Phase Today - Breaking & Trending Today
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2021
12.12.2021 - Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today presented positive data from its ongoing global Phase 2 clinical ... Seite 1
Source: wallstreet-online.de
UCB Showcases Key Rheumatology Data at ACR Convergence 2021
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its investigational IL-17A and IL-17F inhibitor, bimekizumab, and its TNF...
Source: prnewswire.com
DGAP-News: Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935
DGAP-News: Immunic, Inc. / Key word(s): Study Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935 27.10.2021 / 12:30 The issuer is solely
Source: finanznachrichten.de
Genentech's Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation in Alzheimer's Disease
– Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) –– Gantenerumab is the first and only anti-amyloid antibody being investigated for subcutaneous administration in late-stage trials for the treatment of AD –– Ongoing Phase III GRADUATE program with gantenerumab...
Source: pharmiweb.com